IPTA 2025 - Mobis

Posters: Liver/Intestine Posters - from P2.35 to P2.56

Saturday September 20, 2025 from 17:40 to 18:40

MOA 10 (Exhibit Area)

Lectures

P2.35 Living donor liver transplantation in children: safe, sustainable, and successful — Insights from a single-centre: 5-year experience

Sonal Asthana, India
P2.36 Exploring incidence and outcomes of postoperative hypertension requiring antihypertensive continuous infusions in a pediatric liver transplant population”

Mihaela Damian, United States
P2.37 Liver transplantation combined with pancreatectomy for the treatment of metastatic pancreatoblastoma-three cases.

Dr. chong dong, People's Republic of China
P2.38 The diversification of pediatric liver transplant indications: Single center experience with non-cirrhotic inborn errors of metabolism

Ms. Isabel González-Barba Neira, Spain
P2.39 Finding the missing link: Vasospasm in pediatric liver transplant recipients with non-cirrhotic inborn errors of metabolism

Ms. Isabel González-Barba Neira, Spain
P2.40 Better safe than sorry: Minimizing arterial complications in Alagille syndrome liver transplant recipients

Ms. Isabel González-Barba Neira, Spain
P2.41 The order of factors may alter the product: different surgical approaches to pediatric combined heart and liver transplantation (CHLT)

Ms. Isabel González-Barba Neira, Spain
P2.42 Succesfull treatment of biliary rhabdomyosarcoma with neo-adjuvant chemotherapy and liver transplantation

Emre Karakaya, Turkey
P2.43 Remarkable success in heterotopic auxiliary liver transplantation in children and adult: The longest- living patients in the literature

Emre Karakaya, Turkey
P2.44 Management of early vascular complications in pediatric liver transplantation: challenges and solutions

Emre Karakaya, Turkey
P2.45 Prevalence of Eosinophilic Esophagitis after Intestinal transplantation

Dr. Khalid M Khan, United States
P2.46 Unique Proinflammatory Phenotype following Liver transplantation for Wolcott- Rallison Syndrome

Dr. Khalid M Khan, United States
P2.47 Outcomes of liver transplantation in children with Alagille syndrome

Dr. Ivone Malla, Argentina
P2.48 Cardiac arrest during pediatric liver transplant with living donor. Difficult decisions

Dr. Ivone Malla, Argentina
P2.49 Twenty-year review of the paediatric liver transplant program at Red Cross War Memorial Children’s Hospital (RCWMCH)

Mignon McCulloch, South Africa
P2.50 Breadth of Care: Modern Treatment Options for Pediatric Portal Vein Thrombosis

Rebecca Mercedes, United States
P2.51 Sirolimus monotherapy for maintenance of immunosuppression after pediatric liver transplant

Dr. Sanjay Rao, India
P2.53 Assessment of long-term outcomes of pediatric liver transplant recipients

Adem Safak, Turkey
P2.54 Living donor liver transplantation with a portal vein less than two millimeters in diameter

Adem Safak, Turkey
P2.55 Early Complications and Outcomes of Liver Transplantation in Children with Cystic Fibrosis

Marek Stefanowicz, Poland
P2.56 Pediatric Non-A–E Hepatitis and Liver Transplantation: A 15-Year Review across the COVID-19 Era

Dr. Sofia Tsaka, Germany